| Mark J. Tarr | President and Chief Executive Officer | FY2025 | |
| Douglas E. Coltharp | Executive Vice President and Chief Financial Officer | FY2025 | |
| Patrick Darby | Executive Vice President, General Counsel and Secretary | FY2025 | |
| Elissa J. Charbonneau | Chief Medical Officer | FY2024 | |
| Patrick W. Tuer | Executive Vice President and Chief Operating Officer | Not disclosed | — |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.